Type “how to live longer” into Google and you’ll get a wall of peptides. Injections for strength. Injections for fat loss. Something that supposedly heals you like Wolverine. Something that claims to buy you a few extra decades.
We all want the magic button. I would also enjoy waking up with perfect joints, a calm nervous system, a 25-year-old recovery speed, and the metabolism of a golden retriever puppy. Rude that biology has declined my request.
So the honest question is: do peptides work?
What even is a peptide?
Your body is built from protein: muscle, skin, enzymes, hormones, immune signals, and plenty of weird little biological errands happening while you’re trying to remember where you put your keys.
Proteins are made from amino acids. Picture beads on a string. A short string is a peptide. A longer string that folds into a working 3D shape is a protein. Peptides are not exotic. Your body makes them constantly.
Insulin is a peptide. GLP-1 is a peptide. Oxytocin is a peptide. Collagen fragments are peptides. Some peptides are powerful medicines. Some are skin-care ingredients. Some are research chemicals sold with words like “regenerative” and “optimization,” which is usually my cue to squint.
Peptide drugs can be real. Peptide marketing can be ridiculous.
This is the part people mess up. They hear “peptides work” and apply that to every vial, capsule, and face cream on the internet.
That’s not how evidence works.
| Category | Example | What the evidence can support |
|---|---|---|
| FDA-approved peptide drugs | Semaglutide, tirzepatide, tesamorelin, bremelanotide, setmelanotide | Specific medical uses, specific doses, specific populations |
| Promising but disease-specific peptides | Thymosin beta-4/RGN-259, thymosin alpha-1 | Some trial signals in eye, wound, immune, or infection contexts |
| Biomarker peptides | Sermorelin, CJC-1295, ipamorelin, hexarelin | Can raise GH/IGF-1 markers; clinical benefits are much less proven |
| Wellness hype peptides | BPC-157, TB-500, MOTS-c, epitalon, AOD-9604 | Mostly animal data, early data, weak human evidence, or no completed human efficacy trials |
Do GLP-1 drugs like Ozempic work? Yes.
GLP-1 stands apart because of the receipts. The first drug in this family was approved in 2005, so there are about 20 years of real-world use and clinical follow-up. Cardiovascular outcome trials enrolled tens of thousands of people before the SELECT trial added another 17,000-plus people with cardiovascular disease and overweight or obesity.12
Your gut makes GLP-1 after you eat. It nudges insulin, slows stomach emptying, and tells your brain you’re full. Natural GLP-1 disappears fast. Semaglutide is modified so it lasts much longer.
The weight-loss results are real: about 15% average body-weight loss with semaglutide in STEP 1, and 20 to 22% with tirzepatide in SURMOUNT-1.34 SELECT also found 20% fewer major cardiovascular events in people with established cardiovascular disease and overweight or obesity.2
The catch: biology comes back when the drug stops. In the STEP 1 extension, people regained about two-thirds of the weight they had lost within a year after stopping semaglutide and lifestyle support.5 That regain shows how persistent obesity biology is, and it is why long-term treatment decisions belong with a qualified clinician.
Also, weight lost is not all fat. Trials measure lean mass, which includes muscle, water, glycogen, organs, and other fat-free tissue. Some lean mass loss is expected during weight loss, so protein and resistance training matter if you’re using one of these medications.
Retatrutide: powerful, promising, still in testing
Retatrutide is a newer peptide drug being studied for obesity. It activates three receptors: GIP, GLP-1, and glucagon. In a phase 2 trial, the highest dose produced about 24% average weight loss at 48 weeks, with larger phase 3 trials underway.6
That is a big signal. It is also still trial data. Retatrutide is not approved for sale yet, and we still need the larger studies, longer follow-up, safety data, and real prescribing guidance.
The Wolverine peptides: BPC-157 and TB-500
BPC-157 and TB-500 get sold together as the “Wolverine stack.” Great name. Extremely Marvel. Less great evidence.
A 2025 review found 36 BPC-157 studies: 35 in animals and one human chart review of 12 people.7 A tiny IV safety pilot in 2 people has also been published, but that does not prove it heals tendons, guts, joints, muscles, or anything else people are buying it for.8
TB-500 has no completed human efficacy trials for the common recovery claims. Full-length thymosin beta-4 has been studied in some eye and wound-healing contexts, but that does not prove TB-500 injections work for healthy adults trying to recover faster.9
What about the other popular peptides?
Here’s the quick evidence chart. This is the part I’d want in front of me before I paid anyone to inject anything into my body.
| Peptide | Human evidence | Wellness claim read |
|---|---|---|
| Tesamorelin | Strong RCT evidence for reducing visceral abdominal fat in adults with HIV-associated lipodystrophy.10 | Strong, narrow use Not a general weight-loss or anti-aging drug. |
| Bremelanotide / PT-141 | FDA-approved for acquired, generalized HSDD in premenopausal women. Benefit is modest; nausea is common.11 | Real drug, narrow use Not metabolism, body composition, or performance. |
| Setmelanotide | Evidence-based for rare genetic, syndromic, or hypothalamic obesity. | Real drug, rare use Not everyday weight loss. |
| Sermorelin | Raises GH/IGF-1 in small human studies. Healthy female outcome data are tiny and not convincing. | Weak for wellness A hormone marker is not a health outcome. |
| CJC-1295 | Small short studies show GH/IGF-1 increases.12 | Weak No good proof of fat loss, strength, longevity, or recovery benefits. |
| Ipamorelin / hexarelin | Mostly acute GH-release studies in small samples. | Weak Biomarker data, not body recomposition proof. |
| AOD-9604 | Human safety exposure exists, but convincing peer-reviewed weight-loss efficacy is lacking. | Not convincing The “fat-loss peptide” pitch outruns the data. |
| MOTS-c | No completed administered human efficacy trials found; trials are still emerging. | Experimental Interesting biology, no proven human benefit yet. |
| Epitalon / epithalon | Older studies and cell/telomere data; limited independent replication and unclear product equivalence. | Very low confidence Not enough to claim human longevity benefits. |
| GHK-Cu | Limited topical skin data; one small post-laser study did not show objective skin-quality improvement vs control, though satisfaction improved.13 | Maybe modest topical use Face cream is different from injectable anti-aging claims. |
| Melanotan II | Human data mostly tanning/sexual-function related; product-quality and adverse-event concerns exist.14 | Unapproved and risky Skip tanning injections. |
Do peptide face creams work?
Peptide face creams deserve a separate answer because skin is local. A cream does not need to reach your bloodstream to affect how skin looks or feels.
Some small cosmetic peptides may penetrate the upper layers of skin in the right formula. GHK-Cu is a small copper-binding tripeptide, roughly around 400 Daltons as a copper complex, so size alone does not automatically block it. But skin penetration depends on more than size: charge, formula, concentration, skin barrier, and whether the peptide is modified to move through skin better.
For GHK-Cu, the human evidence is limited. In a small post-CO2-laser study, topical copper tripeptide did not objectively improve erythema, wrinkles, or overall skin quality compared with control, though patients reported higher satisfaction.13 That supports “maybe modest cosmetic benefit,” not “proven skin regeneration.”
| Skin-care ingredient | Evidence confidence | My read |
|---|---|---|
| Sunscreen | Very high | The boring undefeated champion. |
| Retinoids | High | Best-studied topical anti-aging category. |
| AHAs/BHAs | Moderate to high | Helpful for texture, acne, and exfoliation when tolerated. |
| Niacinamide | Moderate | Useful, gentle, formula-dependent. |
| GHK-Cu/copper peptides | Low to moderate | Optional add-on. Don’t mortgage your face for it. |
| Random “peptide complex” cream | Usually low | Ask whether the finished product was tested. |
Do peptides have to be injected?
For whole-body drug effects, many peptides are injected because peptides are fragile. Swallow most of them and your gut treats them like food, breaking them into amino acids. Rub most larger peptides on intact skin and very little gets where it would need to go.
But “all peptides have to be injected” is too broad. The route depends on the job.
If a peptide is being sold as an injectable research chemical, the risk conversation gets bigger. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness, or manufacturing quality before marketing. Online peptide products can have identity, dose, purity, sterility, and contamination problems.
Clinics sell some peptides that athletes can’t use
Several popular peptides are prohibited or high-risk under WADA/USADA categories, especially BPC-157, TB-500/thymosin beta-4 derivatives, MOTS-c, tesamorelin, sermorelin, CJC-1295, ipamorelin, AOD-9604, and other GH-axis products.1516
That matters even if a clinic offers it. “A med spa sold it to me” is not an anti-doping defense, and it is not proof the product is safe or effective.
What really works
A hundred years ago, average U.S. life expectancy was much lower than it is today. We gained decades mostly through sanitation, vaccines, antibiotics, safer births, less smoking, better heart care, and better treatment of disease. Those are the proven methods that added years to human life. No peptide did that.
That’s why the boring basics still matter. They’ve been tested in real people for decades, while most hyped peptides are still working their way through animal studies.
The proven ways to support longevity, ranked
The biggest jump comes from going from nothing to a little. In a large harmonized analysis, the least active adults had much higher mortality risk than the most active adults.17 Most benefit starts before you become a fitness influencer, thank God.
Across millions of people, mortality risk tends to sit lowest in a healthy BMI range, while risk rises at higher BMI levels.18 Weight is one risk marker among many. It says nothing about your worth as a person. If weight loss is your goal, here’s how to lose weight and keep it off.
Resistance training protects muscle, function, and bone density. In the LIFTMOR trial, high-intensity resistance and impact training improved bone measures in postmenopausal women with low bone mass.19
Higher fruit and vegetable intake is linked with lower mortality risk, with much of the benefit around five servings per day.20 Produce lowers risk. It does not cure cancer. We can be adults about broccoli. And if you’re weighing organic versus conventional, here’s what the evidence says.
Sleep duration and sleep regularity both show links with health outcomes. Regular sleep-wake timing has been associated with lower mortality risk in large observational data.21
Alcohol is a Group 1 carcinogen and is linked to several cancers. Breast cancer risk rises even at lower levels of intake.2223 There is more on the alcohol evidence on the Wellness AF Club podcast.
Stress matters, but the wellness industry often oversells it because “buy my cortisol detox” is easier to monetize than “go for a walk and call your friend.” Meditation and therapy can help mood and coping. Lifespan claims need stronger evidence.
Knowing what works is the easy part
The hard part is doing it when you’re tired, busy, stressed, and surrounded by food decisions all day. That’s what the Wellness AF app is for: one short lesson at a time, turned into one small habit you can keep.
Get the appThe Newsletter
Get the science, minus the hype
One evidence-based email a week. The real research, in plain English, and what to do with it.
Peptides FAQ
Do peptides really work?
Some do. GLP-1 drugs are proven. Some non-GLP-1 peptide drugs are evidence-based for narrow diagnoses. Most peptides sold for anti-aging, recovery, fat loss, and “optimization” have weak or no human efficacy evidence for those claims.
Is Ozempic a peptide?
Yes. Semaglutide, the drug in Ozempic and Wegovy, is a longer-lasting version of GLP-1, a peptide your gut releases after you eat.
Is retatrutide available yet?
No. Retatrutide is still being studied. In phase 2 data, the highest dose produced about 24% average weight loss at 48 weeks, and phase 3 trials are underway.
What is the Wolverine peptide?
That nickname usually refers to BPC-157 and TB-500, sold for injury recovery and healing. Human efficacy evidence for those recovery claims is not established.
Is BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved. Human evidence is extremely limited, and the common tendon, gut, joint, and muscle-healing claims are not supported by solid human trials.
Do peptide face creams work?
Some small cosmetic peptides may have local skin effects in the right formula. For GHK-Cu, the human evidence supports a cautious “maybe modest cosmetic benefit,” not proven skin regeneration. Topical skin-care peptides are not the same as injectable peptide drugs.
Do peptides have to be injected?
For systemic drug effects, many peptides are injected because oral and skin absorption are difficult. But some topical peptides may act locally in skin, and oral peptide drugs can work when they use proven delivery systems. Route matters.
What is the best way to biohack for longevity?
The strongest basics are still movement, healthy weight range, resistance training, fruits and vegetables, sleep, less alcohol, and not smoking. They are boring because they have been counted in real humans for decades. If you want help turning them into daily habits, the Wellness AF app walks you through one small step at a time.
Studies & sources
- GLP-1 cardiovascular trials: Sattar 2021, Lancet Diabetes & Endocrinology.
- SELECT cardiovascular outcomes trial: Lincoff 2023, New England Journal of Medicine.
- STEP 1 semaglutide obesity trial: Wilding 2021, New England Journal of Medicine.
- SURMOUNT-1 tirzepatide obesity trial: Jastreboff 2022, New England Journal of Medicine.
- STEP 1 extension after stopping semaglutide: Wilding 2022, Diabetes, Obesity and Metabolism.
- Retatrutide phase 2 obesity trial: Jastreboff 2023, New England Journal of Medicine.
- BPC-157 review: Vasireddi 2025, HSS Journal.
- BPC-157 tiny human IV safety pilot: PMID 40131143.
- Thymosin beta-4/RGN-259 ocular healing trial: PMID 36613994.
- Tesamorelin HIV lipodystrophy RCT: Falutz 2010, Journal of Clinical Endocrinology & Metabolism. PMID 20101189.
- Bremelanotide RECONNECT trials: Kingsberg 2019, Obstetrics & Gynecology. PMID 31429064.
- CJC-1295 GH/IGF-1 pharmacodynamic studies: PMID 16352683.
- Topical copper tripeptide after CO2 laser resurfacing: PMID 16847171.
- Melanotan II product testing and safety concerns: PMID 24771717; PMID 33460908; PMID 31953620.
- USADA: BPC-157 experimental peptide prohibited.
- USADA: MOTS-c peptide warning.
- Physical activity and mortality: Ekelund 2019, BMJ.
- BMI and mortality: Global BMI Mortality Collaboration 2016, Lancet.
- LIFTMOR bone trial: Watson 2018, Journal of Bone and Mineral Research.
- Fruit and vegetable intake and mortality: Aune 2017, International Journal of Epidemiology.
- Sleep regularity and mortality: Windred 2024, Sleep.
- Alcohol and cancer advisory: U.S. Surgeon General, 2025.
- Alcohol and breast cancer: Collaborative Group 2002, British Journal of Cancer.
This article is for education, not medical advice. Decisions about medications, compounded peptides, injections, skin treatments, supplements, or any health routine belong between you and a qualified healthcare professional.